Effects of the MiniMed770G System Hybrid Closed Loop(HCL)

Effects of the MiniMed770G System Hybrid Closed Loop(HCL) - Effects of the MiniMed770G System Hybrid Closed Loop(HCL)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050286

Enrollment

Registered

2023-02-09

Start date

2022-03-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Type 1 diabetes treated sensor-augmented pump (2)Patients whose insulin pump will be changed to MiniMed 770G (3)6 years old or older, under 85 years old

Exclusion criteria

Exclusion criteria: (1)Persons deemed inappropriate by the Principal Investigator or Research Assistants (2)Patients who requested not to participate in this study

Design outcomes

Primary

Measure	Time frame
Change in TIR (70-180 mg/dL time)before and after introduction of HCL	—

Secondary

Measure	Time frame
TBR(time below renge) TAR(time above range) Average sensor glucose level HbA1c	—

Countries

Japan

Contacts

Public ContactAtsuhito Tone

Okayama Saiseikai General Hospital internal medicine

aitone@ms1.megaegg.ne.jp086-252-2211

Outcome results